Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis
Eurasian Journal of Medicine and Oncology · 07.07.2026 · 026110126
DOI: 10.36922/ejmo026110126 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 07.07.2026. Verfasst von Ganchimeg Dondov und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Recent studies have shown that serological biomarkers such as pepsinogens may facilitate the early detection of gastric cancer.
Objective
This study aims to evaluate the diagnostic performance of serum pepsinogen I (PGI) and the PGI/pepsinogen II ratio (PGR) in detecting gastric cancer and chronic atrophic gastritis.
Methods
A systematic literature search was conducted using MeSH terms related to atrophic gastritis, gastric neoplasms, pepsinogen A, sensitivity, and specificity. Twenty-one eligible studies were included in the quantitative synthesis.
Results
For atrophic gastritis, the area under the curve was 0.74 (95% confidence interval [CI] = 0.70–0.77) for PGI and 0.78 (95% CI = 0.75–0.82) for PGR. The pooled sensitivity and specificity were 61.4% (95% CI = 48.2–73.2) and 86.4% (95% CI = 61.8–96.1), respectively, for PGI, and 72.4% (95% CI = 61.0–81.4) and 76.9% (95% CI = 49.5–91.9), respectively, for PGR. For gastric cancer detection, the area under the curve values were 0.76 (95% CI = 0.72–0.80) for PGI, 0.77 (95% CI = 0.73–0.80) for PGR, and 0.79 (95% CI = 0.75–0.83) for the combined PGI+PGR model. The pooled sensitivity and specificity were 69.8% (95% CI = 55.0–81.3) and 70.8% (95% CI = 58.7–80.6), respectively, for PGI, 76.2% (95% CI = 65.4–84.2) and 66.1% (95% CI = 56.1–74.8), respectively, for PGR, and 61.5% (95% CI = 50.9–72.1) and 86.7% (95% CI = 79.4–94.1), respectively, for PGI+PGR.
Conclusion
Serum PGI and PGR can be used as an additional screening for high-risk subjects who may require gastroscopy or biopsy.
Zitieren
APA
Dondov, G., Nyamaa, B., Batsaikhan, B., Badamjav, T., Lkhagvasuren, S., & Lonjid, T. (2026). Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis. Eurasian Journal of Medicine and Oncology, 0(0), 026110126. https://doi.org/10.36922/ejmo026110126
Vancouver
Dondov G, Nyamaa B, Batsaikhan B, Badamjav T, Lkhagvasuren S, Lonjid T. Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis. Eurasian Journal of Medicine and Oncology. 2026;0(0):026110126. doi:10.36922/ejmo026110126
BibTeX
@article{Dondov2026,
author = {Dondov, Ganchimeg and Nyamaa, Bayarmaa and Batsaikhan, Batbold and Badamjav, Tegshjargal and Lkhagvasuren, Sodnomtsogt and Lonjid, Tulgaa},
title = {Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {026110126},
doi = {10.36922/ejmo026110126}
}
EUVIMED